OTR Acquisition Corp.

Status: Deal Closed
U=S+W/2 W=S@11.5
IPO Proceeds, $M $104.77M
IPO Date Nov 17, 2020
CEO Nicholas J. Singer
Left Lead Maxim
IPO Cash in Trust 102.2%
SPAC Tenor 18 months
IPO Sector General

Not specified

IPO Geography Global
Target Company Comera Life Sciences
Deal Announced Jan 31, 2022
Deal Size, $M $151.30M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote May 10, 2022
Amendment Vote TBD
Closing Date May 19, 2022
Formerly OTRA CMRA CMRAW

Sign up for Free Trial

No credit card required

Sign in for more on OTR Acquisition Corp.:

  • Structure and cap table
  • 6 directors & officers
  • 25 filings and events
  • 2 underwriters
  • 1 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Nicholas J. Singer 41 CEO and Chairman
Douglas B. Anderson 51 CFO and Director
David Neithardt 51 Director
Glenn Gray 66 Director
Nadav Besner 41 Director
Mr. Amir Rozwadoski Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Maxim BR 8,052,500 units
EarlyBirdCapital 1,947,500
10,000,000 units
Up-Front UW fee 1.25 %
Deferred UW fee 3.24 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 25 filings.

Shareholders

Sign in to view shareholders 13F filing data.